Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT

NCT05814731 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Haploidentical Stem Cell Transplantation
Conditioning

Interventions

DRUG: MA-BUCY2
DRUG: BUCY2

Sponsor

First Affiliated Hospital Xi'an Jiaotong University